Synthesis and study of antibacterial and antifungal activities of Novel 2-[[(benzoxazole/benzimidazole-2-yl)sulfanyl] acetylamino]thiazoles

Archives of Pharmacal Research

Volumn 27, Issue 11, 2004, Pages 1081-1085

  Kaplancikli, Zafer Asim ^b   Turan Zitouni, Gülhan ^b   Revial, Gilbert ^a,b   Guven, Kiymet ^b  

^a CNRS   (France)

^b ANADOLU UNIVERSITY   (Turkey)

Author keywords

Antimicrobial activity; Benzimidazole; Benzoxazole; Thiazole

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BENZIMIDAZOLE DERIVATIVE; THIAZOLE DERIVATIVE;

ARTICLE; BACILLUS CEREUS; CANDIDA ALBICANS; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; ESCHERICHIA COLI; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGICAL EXAMINATION; MICROCOCCUS; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACILLUS CEREUS; BENZIMIDAZOLES; CANDIDA ALBICANS; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MICROCOCCUS; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES;

EID: 16644397423     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/BF02975108     Document Type: Article

References (30)

1. Alexander, B. D. and Perfect, J. R., Antifungal resistance trends towards the year 2000 Implications for therapy and new approaches.Drugs, 54, 657–678 (1997)
2. Amyes, S. G. B. and Gemmell, C. G., Antibiotic resistance-Proceedings of a symposium held on 12 July 1996 at the University of Southampton.J. Med. Microbiol., 46, 436–470 (1997) DOI: 10.1099/00222615-46-6-436
3. Ates, Ö., Altintas, H. and Ötük, G., Synthesis and antimicrobial activity of 4-carbethoxymethyl-2-[(alpha-haloacyl)amino] thiazoles and 5-nonsubstituted/substituted 2-[(4-carbethoxymethylthiazol-2-yl) imino]-4-thiazolidinones.Arzneim. Forsch., 50, 569–575 (2000).
4. Cassell, G. H. and Mekalanos, J., Development of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance.J. Am. Med. Assoc., 285, 601–605 (2001). DOI: 10.1001/jama.285.5.601
5. Cetinkaya, Y., Falk, P., and Mayhall, C.G., Vancomycin-resistant enterococci.Clin. Microbiol. Rev., 13, 686–707 (2000). DOI: 10.1128/CMR.13.4.686-707.2000
6. Chu, D. T. W., Plattner, J. J., and Katz, L., New directions in antibacterial research.J. Med. Chem., 39, 3853–3874 (1996). DOI: 10.1021/jm960294s
7. Cunha, B. A., Antibiotic resistance.Drugs Today, 34, 691–698 (1998).
8. Doern, G. V., Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States.Clin. Infect. Dis., 33, 187–192 (2001). DOI: 10.1086/321847
9. Goodman-Gilman, A.,The pharmacological basis of therapeutics. McGraw-Hill company, USA, (2001).
10. Gringauz, A.,Introduction to Medicinal Chemistry, How Drug Act and Why, Wiley-VCH Inc., USA (1997).
11. Healy, V. L., Lessard, I. A. D., Roper, D. I., Knox, J. R. and Walsh, C. T., Vancomycin resistance in enterococci: reprogramming of the D-Ala-D-Ala ligases in bacterial peptidoglycan biosynthesis.Chem. Biol., 7, 109–119 (2000). DOI: 10.1016/S1074-5521(00)00116-2
12. Hood, S. and Denning, D. W., Treatment of fungal infection in AIDS,J. Antimicrob. Chemoth., 37, 71–85 (1996).
13. Hubschwerlen, C., Pflieger, P., Specklin, J. L., Gubernator, K., Gmunder, H., Angehrn, P., and Kompis, I., Pyrimido[1,6a] benzimidazoles: a new class of DNA gyrase inhibitors.J. Med. Chem., 35, 1385–1392 (1992). DOI: 10.1021/jm00086a006
14. Joule, J. A. and Mills, K.,Heterocyclic Chemistry, Blackwell Science Ltd., Oxford, (2000)
15. Kim J. S., Sun, Q., Gatto, B., Yu, C., Liu, A., Liu, L. F., and LaVoie, E. J., Structure-activity relationships of benzimidazoles and related heterocycles as topoisomerase I poisons.Bioorg. Med. Chem., 4, 621–630 (1996). DOI: 10.1016/0968-0896(96)00047-8
16. Koneman, E. W., Allen, S. D., and Winn, W. C.,Colour Atlas and Textbook of Diagnostic Microbiology, Lippincott Raven Pub., Philadelphia, (1997).
17. Lakhan, R., Sharma, B. P., and Shukla, B. N., Synthesis and antimicrobial activity of 1-aryl-2-amino-3-(4-arylthiazol-2-yl)/(benzothiazol-2-yl) guanidines.Farmaco, 55, 331–337 (2000). DOI: 10.1016/S0014-827X(00)00032-X
18. Levy, S. B., The challenge of antibiotic resistance.Sci. Am., 278, 46–53 (1998). DOI: 10.1038/scientificamerican0398-46
19. Lipsitch, M., The rise and fall of antimicrobial resistance.Trends Microbiol., 9, 438–444 (2001). DOI: 10.1016/S0966-842X(01)02130-8
20. Lopez-García, B., Veyrat, A., Peŕez-Payá, E., González-Candelas, L., and Marcos, J. F., Comparison of the activity of antifungal hexapeptides and the fungicides thiabendazole and imazalil against postharvest fungal pathogens.Int. J. Food Microbiol., 89, 163–170, (2003) DOI: 10.1016/S0168-1605(03)00118-1
21. Marchese, A., Schito, G. C., and Debbia, E. A., Evolution of antibiotic resistance in gram-positive pathogens.J. Chemotherapy, 12, 459–462 (2000).
22. Onoe, H. and Takahashi, H.,Jpn. Kokai. Tokkyo Koho JP 03 87, 841 (1994).Chem. Abstr., 121, 205336 (1994).
23. Pandeya, S. N., Sriram, D., and Nath, G., Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives andN-[4-(4′-chlorophenyl) thiazol-2-yl] thiosemicarbazide.Eur. J. Pharm. Sci., 9, 25–31 (1999). DOI: 10.1016/S0928-0987(99)00038-X
24. Perrin, L., Rakik, A., Yerly, S., Baumberger, C., Kinlochde-Loes, S., Pechere, M., and Hirschel, B., Combined therapy with zidovudine and L-697, 661 in primary HIV infection.AIDS, 10, 1233–1237 (1996). DOI: 10.1097/00002030-199609000-00009
25. Rapp, R. P., Antimicrobial resistance in gram-positive bacteria: The myth of the MIC.Pharmacotherapy, 19, 112–119 (1999). DOI: 10.1592/phco.19.12.112S.31703
26. Rybak, M. J. and Akins, R. L., Emergence of methicillin-resistant Staphylococcus aureus with intermediate glycopeptide resistance-Clinical significance and treatment options.Drugs, 6, 1–7 (2001). DOI: 10.2165/00003495-200161010-00001
27. Silverman, R. B.,Organic chemistry of Drug Desing and Drug Action, Academic press, San Diego, (1992).
28. Thompson, L. A. and Ellman, J. A., Synthesis and applications of small molecule libraries.Chem. Rev., 96, 555–600 (1996). DOI: 10.1021/cr9402081
29. Turan-Zitouni, G. and Kaplancikli, Z. A., Some new 2,3-dihydro-3-benzofuranamine derivatives.Boll. Chim. Farmaceutico, 137, 367–371 (1998).
30. Turan-Zitouni, G., Demirayak, S., Özdemir, A., Kaplancikli, Z. A., and Yildiz, M. T., Synthesis of some 2-[(benzazole-2-yl) thioacetylamino]thiazole derivatives and their antimicrobial activity and toxicity.Eur. J. Med. Chem., 39, 267–272 (2004). DOI: 10.1016/j.ejmech.2003.11.001